Abstract | BACKGROUND: METHODS/RESULTS: CONCLUSIONS: This case demonstrates that clinical benefits can be obtained by beginning aggressive treatment of OTC-D within a few hours of the onset of severe neurological symptoms even in the absence of altered biochemical markers.
|
Authors | Albina Tummolo, Vito Favia, Rosa Bellantuono, Vito Bellino, Antonio Ranieri, Amelia Morrone, Tommaso De Palo, Francesco Papadia |
Journal | Pediatric emergency care
(Pediatr Emerg Care)
Vol. 29
Issue 5
Pg. 656-8
(May 2013)
ISSN: 1535-1815 [Electronic] United States |
PMID | 23640148
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glutamates
- Phenylbutyrates
- N-carbamylglutamate
- Citrulline
- Arginine
- Carnitine
|
Topics |
- Adolescent
- Arginine
(therapeutic use)
- Brain
(diagnostic imaging)
- Carnitine
(therapeutic use)
- Case Management
- Citrulline
(therapeutic use)
- Coma
(blood, etiology, therapy)
- Combined Modality Therapy
- Drug Therapy, Combination
- Electroencephalography
- Female
- Glutamates
(therapeutic use)
- Hemofiltration
- Humans
- Hyperammonemia
(etiology)
- Lethargy
(etiology)
- Ornithine Carbamoyltransferase Deficiency Disease
(blood, complications, drug therapy)
- Phenylbutyrates
(therapeutic use)
- Renal Dialysis
- Tomography, Emission-Computed, Single-Photon
- Vomiting
(etiology)
|